The Biology of MTP: Why Symptoms and Diagnosis Vary

Understanding the “why” and “how” of Mitochondrial Trifunctional Protein (MTP) deficiency can help you feel more in control of your or your child’s care. This condition is not just one disease but a spectrum of symptoms caused by a specific breakdown in how the body handles energy.

The Biological “Power Failure”

To understand MTP deficiency, it helps to think of the body as a hybrid engine. Most of the time, the engine runs on glucose (sugar). When sugar runs low—such as during sleep, exercise, or illness—the body should switch to burning fat for fuel ^[1].

In MTP deficiency, the “switch” is broken. The MTP enzyme complex is responsible for the last three steps of breaking down long-chain fatty acids ^[2]. When these steps cannot happen:

1. Energy Crisis: The body cannot produce the energy it needs to keep the heart, brain, and muscles running during times of stress ^[1].
2. Toxic Buildup: Instead of being turned into energy, the fats are partially broken down into “intermediates” called long-chain 3-hydroxy fatty acids ^[3]. These substances can be toxic, specifically damaging the heart, liver, and nerves ^[4][5].

One Condition, Different Faces

MTP deficiency looks different for every patient. Doctors generally group the symptoms into three main “phenotypes” (clinical presentations) based on when they start and which organs are most affected ^[6]:

1. Severe Neonatal Form

This is the most critical version, appearing shortly after birth.

• Heart and Liver: Babies may experience cardiomyopathy (an enlarged, weak heart) or rapid liver failure ^[5][7].
• Urgency: Because it affects vital organs so early, this form requires immediate and intensive medical intervention ^[5].

2. Infantile (Intermediate) Form

Symptoms usually appear in the first year of life, often triggered by a common cold or a long stretch without eating.

• Metabolic Crisis: The child may have dangerously low blood sugar (hypoglycemia) or become very lethargic ^[1].
• Systemic Symptoms: While the heart may be affected, the main risks are related to energy failure during illness ^[7].

3. Late-Onset (Myopathic) Form

This milder form may not be diagnosed until childhood, adolescence, or even adulthood ^[6].

• Muscle and Nerves: The main symptoms are rhabdomyolysis (muscle breakdown during exercise or illness), exercise intolerance, and peripheral neuropathy (tingling or weakness in the hands and feet) ^[7][8].
• Vision: Some patients develop pigmentary retinopathy, a gradual change in the back of the eye that can affect vision ^[9][10].

Why the Diagnosis is Often Complex

You may wonder why multiple tests were needed, or why a “normal” newborn screen didn’t catch it immediately.

The Limits of Screening

Standard newborn screening uses a test called acylcarnitine profiling to look for “red flags” in the blood. While this is excellent at catching severe cases, it can sometimes miss “milder” or “attenuated” forms of MTP deficiency because the fat levels in the blood might look normal when the patient is healthy ^[11][6].

The Need for Genetic Testing

Because the symptoms can overlap with other conditions, a definitive diagnosis requires looking at the DNA (the HADHA and HADHB genes) ^[11]. Genetic testing is the “gold standard” because:

• It confirms exactly which gene is affected ^[12].
• It helps doctors predict which “form” of the disease a patient might have ^[6].
• In some cases, if genetic results are unclear, doctors may perform an enzymatic assay—testing a small sample of skin cells (fibroblasts) in a lab to see exactly how well the MTP enzyme is working ^[11][13].